Carbohydrate Metabolism: Glycogen, HMP Shunt & Diabetes

Carbohydrate metabolism is how the body manages its sugar economy: storing glucose as glycogen after meals, releasing it between meals, and shunting some into the hexose monophosphate (HMP) pathway for building materials. When this economy breaks down, the result is diabetes — the defining metabolic disease of our time.

This matters enormously in India, which carries one of the world's largest diabetes burdens. Blood sugar control, HbA1c testing, and diabetes drugs all target these exact pathways. The HMP shunt also explains why some people develop anaemia from certain antimalarial drugs.

Key Concepts

• Glycogenesis: building glycogen from glucose, driven by insulin after meals; the key enzyme is glycogen synthase.
• Glycogenolysis: breaking glycogen back to glucose, driven by glucagon and adrenaline during fasting or stress; the key enzyme is glycogen phosphorylase.
• HMP shunt (pentose phosphate pathway): an alternative route for glucose-6-phosphate making NADPH (for fat synthesis and antioxidant defence) and ribose-5-phosphate (for DNA and RNA). Its gatekeeper is glucose-6-phosphate dehydrogenase (G6PD).
• Oxidative vs non-oxidative phase: the oxidative phase irreversibly makes 2 NADPH per glucose-6-phosphate; the non-oxidative phase reshuffles sugars reversibly.
• Insulin resistance: the core of type 2 diabetes — cells respond poorly to insulin, so the pancreas overproduces it until it fails.
• HbA1c: glycated haemoglobin reflecting average blood glucose over ~3 months; 6.5% or higher diagnoses diabetes.
• Polyol pathway and AGEs: in chronic high sugar, glucose converts to sorbitol and proteins glycate into advanced glycation end-products — the chemistry behind diabetic eye, kidney, and nerve damage.

Formulas

Net ATP from glycogen-derived glucose: glycogen breakdown releases glucose-1-phosphate, which becomes glucose-6-phosphate without spending ATP (free glucose costs 1 ATP for this step via hexokinase). Glycolysis then makes 4 ATP and spends 1 (at phosphofructokinase). So: net ATP = 4 − 1 = 3 ATP per glucose unit from glycogen, versus 4 − 2 = 2 ATP from free blood glucose. Assumptions: standard glycolysis to pyruvate; limits: under aerobic conditions the totals rise via mitochondria, but the 1-ATP advantage of glycogen holds.

Worked Example

Compare the energy from 100 glucose units taken from muscle glycogen versus 100 from blood glucose. Step 1: glycogen route — 100 × 3 = 300 ATP. Step 2: blood-glucose route — 100 × 2 = 200 ATP. Step 3: difference — 300 − 200 = 100 extra ATP, which is 50% more energy (100 ÷ 200 = 0.5). This is why muscles keep their own glycogen stash: in a sprint, that saved ATP investment means faster energy, which is also why glycogen depletion causes the marathoner's wall.

Common Misconceptions

• Diabetes is caused only by eating too much sugar. Type 2 diabetes is driven by insulin resistance from excess weight, inactivity, and genetics; type 1 is autoimmune.
• The HMP shunt produces ATP. It produces no ATP — its products are NADPH and pentose sugars. Energy is glycolysis's job.
• Glycogen and starch are the same thing. Both are glucose polymers, but glycogen is more branched and is the animal storage form; starch is the plant one.

Real-World Applications

• HbA1c testing monitors diabetes control over months, not minutes.
• G6PD deficiency screening matters before prescribing antimalarials or fava-bean-heavy diets, to avoid haemolytic anaemia.
• Hypoglycaemia is treated with fast glucose because the brain cannot use glycogen or fat directly.
• Metformin, the first-line diabetes drug, works partly by restraining liver glucose output from glycogen.

Carbohydrate metabolism stores glucose as glycogen, spends it through glycolysis with a 1-ATP bonus over free glucose, and diverts some through the HMP shunt to make NADPH and ribose. Insulin and glucagon conduct the switching; when it fails, diabetes follows — and these pathways are the targets of diabetes testing and treatment.